Objectives
tumors
SECONDARY, TUMORS
The study's primary objectives were to determine the MTD and RP2D of metformin combined with VIT in pediatric relapsed and refractory solid and CNS tumors, and to describe pharmacokinetics (PKs) of metformin in combination with VIT. The secondary objective was to describe the radiologic responses seen with this regimen.